4 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... inhibitors during ... Drug interactions ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Angiotensin Receptor ... of another drug ... recalls, this drug ... #Table #Dosing ... #Pharmacology #Dose
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching Between Oral P2Y12 ... of a given drug ... the timing and dosing ... ticagrelor #prasugrel #pharmacology
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANGIOTENSIN II RECEPTOR ... ANTAGONIST (ARB) DOSING ... Doses should be ... ReceptorBlocker #Pharmacology ... #Conversion #Switching